| Bioactivity | Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects[1]. |
| Invitro | Tomuzotuximab has a fully human glycosylation pattern and is glyco-optimised at its Fc domain, while fully retaining the affinity, specificity, EGFR inhibition and induction of apoptosis of Cetuximab[1]. |
| Name | Tomuzotuximab |
| CAS | 1646321-00-7 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |